Claims in vapour device (e-cigarette) regulation: A Narrative Policy Framework analysis |
| |
| Institution: | 1. Centre for Addictions Research of British Columbia, P.O. Box 1700 STN CSC, Victoria, BC V8W 2Y2, Canada;2. Cancer Council Victoria, 615 St. Kilda Road, Melbourne, Victoria 3004, Australia;1. Department of Otolaryngology-Head and Neck Surgery, Eastern Virginia Medical School, Norfolk, VA, USA;2. Children''s Hospital of the King''s Daughters, Norfolk, VA, USA;1. Department of Psychology, Louisiana State University, 236 Audubon Hall, Baton Rouge, LA 70803, USA;2. Department of Psychology, University of Houston, Houston, TX, USA;3. Department of Behavioral Sciences, University of Texas MD Anderson Cancer Center, Houston, TX, USA;1. National Centre for Youth Substance Use Research, The University of Queensland, Australia;2. School of Psychology, The University of Queensland, Australia;3. National Drug and Alcohol Research Centre, University of New South Wales, Australia;4. Discipline of Psychiatry, The University of Queensland, Australia;5. NHMRC Centre of Research Excellence on Achieving the Tobacco Endgame, School of Public Health, Faculty of Medicine, The University of Queensland, Australia;1. Ventana Systems UK Ltd., Alexandra House, St Johns Street, Salisbury, SP1 2SB, UK;2. British American Tobacco (Investments) Ltd., Group R&D, Regents Park Road, Southampton, SO15 8TL, UK;1. Department of Health Promotion, Maastricht University (CAPHRI), P. Debyeplein 1, 6229 HA Maastricht, The Netherlands;2. Alliance Smokefree Holland, Eisenhowerlaan 108, 2517 KL The Hague, The Netherlands;3. Department of Communication, University of Amsterdam (ASCoR), Nieuwe Achtergracht 166, 1018 WV Amsterdam, The Netherlands;4. Trimbos Institute, Netherlands Institute for Mental Health and Addiction, Da Costakade 45, 3521 VS Utrecht, The Netherlands;5. Department of Methodology and Statistics, Maastricht University (CAPHRI), P. Debyeplein 1, 6229 HA Maastricht, The Netherlands;6. Research Division, The Cancer Council Victoria, 1 Rathdowne St, Carlton, Victoria 3053, Australia |
| |
| Abstract: | BackgroundThe electronic cigarette or e-cigarette (vapour device) is a consumer product undergoing rapid growth, and governments have been adopting regulations on the sale of the devices and their nicotine liquids. Competing claims about vapour devices have ignited a contentious debate in the public health community. What claims have been taken up in the state arena, and how have they possibly influenced regulatory outcomes?MethodsThis study utilized Narrative Policy Framework to analyze the claims made about vapour devices in legislation recommendation reports from Queensland Australia, Canada, and the European Union, and the 2016 deeming rule legislation from the United States, and examined the claims and the regulatory outcomes in these jurisdictions.ResultsThe vast majority of claims in the policy documents represented vapour devices as a threat: an unsafe product harming the health of vapour device users, a gateway product promoting youth tobacco uptake, and a quasi-tobacco product impeding tobacco control. The opportunity for vapour devices to promote cessation or reduce exposure to toxins was very rarely presented, and these positive claims were not discussed at all in two of the four documents studied.ConclusionThe dominant claims of vapour devices as a public health threat have supported regulations that have limited their potential as a harm reduction strategy. Future policy debates should evaluate the opportunities for vapour devices to decrease the health and social burdens of the tobacco epidemic. |
| |
| Keywords: | E-cigarettes Narrative Policy Framework Regulation |
| 本文献已被 ScienceDirect 等数据库收录！ |
|
